UnitedHealth Group Inc

Price Chart

About UnitedHealth Group Inc

UnitedHealth Group Incorporated is an American multinational for-profit company specializing in health insurance and health care services based in Eden Prairie, Minnesota. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world’s seventh-largest company by revenue and the largest health care company by revenue.

The company is ranked 8th on the 2024 Fortune Global 500. UnitedHealth Group had a market capitalization of $460.3 billion as of December 20, 2024. It has faced controversies and legal actions related to patient care denials, billing practices, and its market power.

PRESIDENT & CFOJohn F. Rex
FOUNDEDJanuary 1977
HEADQUARTERSSan Francisco, California United States
WEBSITEunitedhealthgroup.com
NUMBER OF EMPLOYEES400,000
SECTORHealthcare
INDUSTRYHealthcare Plans
IndexDJIA, S&P 500
Market Cap268.12B
Income22.11B
Sales410.06B
Book/sh104.44
Cash/sh
Dividend Est.8.69 (2.94%)
Dividend TTM8.40 (2.84%)
Dividend Ex-DateMar 10, 2025
Employees400000
Option/ShortYes / Yes
Sales Surprise-1.80%
SMA20-16.68%
P/E12.36
Forward P/E11.27
PEG5.06
P/S0.65
P/B2.83
P/C
P/FCF10.78
Quick Ratio
Current Ratio0.85
Debt/Eq0.86
LT Debt/Eq0.75
EPS Surprise-1.26%
SMA50-34.37%
EPS (ttm)23.92
EPS next Y26.22
EPS next Q5.2
EPS this Y-17.89%
EPS next Y15.44%
EPS next 5Y2.44%
EPS past 5Y1.60%
Sales past 5Y10.61%
EPS Y/Y TTM45.24%
Sales Y/Y TTM8.68%
EPS Q/Q548.50%
Sales Q/Q9.80%
SMA200-44.00%
Insider Own0.24%
Insider Trans5.34%
Inst Own91.28%
Inst Trans2.97%
ROA7.44%
ROE24.33%
ROI13.29%
Gross Margin
Oper. Margin8.16%
Profit Margin5.39%
Payout52.75%
EarningsApr 17 BMO
Trades194,845
Shs Outstand910.00M
Shs Float905.00M
Short Float0.98%
Short Ratio0.66
Short Interest8.85M
52W Range248.88 – 630.73
52W High-53.14%
52W Low18.76%
RSI (14)27.07
Recom1.83
Rel Volume1.25
Avg Volume13.49M
Volume16,873,638
Perf Week1.25%
Perf Month-30.33%
Perf Quarter-35.96%
Perf Half Y-48.77%
Perf Year-43.55%
Perf YTD-41.57%
Beta0.48
ATR (14)20.21
Volatility3.28% 5.75%
Target Price378.86
Prev Close296.67
Price295.57
Change-0.37%
Information edited and updated on 23/05/2025 

KEY FINANCIALS


Institutional Ownership

VANGUARD GROUP INC9.92%
BlackRock, Inc.8.12%
STATE STREET CORP4.96%
JPMORGAN CHASE & CO2.87%
WELLINGTON MANAGEMENT GROUP LLP2.83%
FMR LLC2.65%
Capital World Investors2.49%
PRICE T ROWE ASSOCIATES INC /MD/2.34%
MORGAN STANLEY2.34%
Capital Research Global Investors2.28%

Insider Trading


Income Statement

PeriodTTMFY 2024FY 2023
Period End Date12/31/202412/31/2023
Period Length12 Months12 Months12 Months
Total Revenue410,057.00400,278.00367,809.00
Losses, Claims & Reserves271,861.00264,185.00241,894.00
Selling, General and Administrative Incl. Other104,721.00103,806.0097,370.00
Operating Income before Interest Expense33,475.0032,287.0028,545.00
Interest Expense4,060.003,906.003,246.00
Unusual Expense
Net Income Before Taxes28,176.0020,071.0029,112.00
Income Taxes5,239.004,829.005,968.00
Consolidated Net Income22,937.0015,242.0023,144.00
Net Income From Continuing Operations22,106.0014,405.0022,381.00
Net Income22,106.0014,405.0022,381.00
EPS (Recurring)24.0815.5123.86
EPS (Basic, Before Extraordinaries)24.0715.6424.12
EPS (Diluted)23.9215.5123.86
Non-Operating Income (Expense)-1,239.00-8,310.000
Other After Tax Adjustments0.000.000.00
Stock Option Compensation Expense896.00937.00
Price To Earnings Ratio12.3612.3632.99
Price To Sales Ratio1.171.171.34
Gross Margin
Operating Margin8.168.077.76
Net Margin5.393.606.08
Shares Outstanding910.00915.00924.00
Market Capitalization268,123.37268,123.37467,320.22
values in Millions, USD

Balance Sheet

PeriodFY 2024FY 2023
Period End Date12/31/202412/31/2023
Total Cash25,312.0025,427.00
Investments47,427.0051,810.00
Premium Balance Receivables – Insurance22,365.0021,276.00
Net Property, Plant & Equipment10,553.0011,450.00
Investment in Unconsolidated Affiliates8,728.000.00
Deferred Tax Assets3,824.004,695.00
Other Intangible Assets183,893.00163,757.00
Total Assets302,102.00278,415.00
Insurance Policy Liabilities – Insurance57,924.0054,695.00
Total Debt81,793.0067,435.00
Long Term Debt76,234.0062,123.00
Provision for Risks Charges2,100.001,900.00
Deferred Tax Liabilities7,444.007,716.00
Other Liabilities50,250.0047,750.00
Total Liabilities199,511.00179,496.00
Non-Equity Reserves0.000.00
Preferred Stock – Carrying Value0.000.00
Common Equity92,658.0088,756.00
Total Shareholders Equity92,658.0088,756.00
Accumulated Minority Interest9,933.0010,163.00
Total Equity102,591.0098,919.00
Total Liabilities & Stockholders Equity302,102.00278,415.00
Book Value Per Share101.2796.06
Tangible Book Value Per Share-40.81-32.65
Full-Time Employees400,000.00440,000.00
Price to Book Ratio2.834.96
Return on Assets4.968.47
Return on Equity15.8826.88
Return on Invested Capital8.5314.83
Quick Ratio
Current Ratio0.830.79
values in Millions, USD

Cash Flow

PeriodTTMFY 2024FY 2023
Period End Date12/31/202412/31/2023
Period Length12 Months12 Months12 Months
Funds from Operations25,712.0025,012.0027,425.00
Extraordinary Item0.000.000.00
Changes in Working Capital2,804.00-808.001,643.00
Income Taxes Payable
Cash from Operating Activities28,516.0024,204.0029,068.00
Capital Expenditures-3,654.00-3,499.00-3,386.00
Net Assets From Acquisitions-11,384.00-13,688.00-10,866.00
Sale of Fixed Assets and Businesses2,041.002,041.00685.00
Purchase or Sale of Investments1,250.00525.00-1,777.00
Purchase of Investments-26,645.00-27,308.00-18,314.00
Sale Or Maturity of Investments27,895.0027,833.0016,537.00
Other Uses-3,103.00-6,186.00-960.00
Other Sources309.000.000.00
Cash from Investing Activities-14,541.00-20,807.00-16,304.00
Cash Dividends Paid-7,716.00-7,533.00-6,761.00
Change in Capital Stock-7,208.00-7,154.00-6,647.00
Repurchase of Common Pref Stock-8,928.00-9,000.00-8,000.00
Sale of Common Pref Stock1,720.001,846.001,353.00
Proceedsfrom Stock Options1,720.001,846.001,353.00
Issuance or Reduction of Debt, Net7,207.0014,660.004,280.00
Change in Long Term Debt9,636.0014,811.004,269.00
Issuance of Long Term Debt11,886.0017,811.006,394.00
Reduction of Long Term Debt-2,250.00-3,000.00-2,125.00
Net Financing Active Other Cash Flow-3,647.00-3,205.00-1,671.00
Other Financing Activities Uses-3,147.00-3,205.00-1,671.00
Cash from Financing Activities-11,364.00-3,232.00-10,799.00
Exchange Rate Effect2.00-61.0097.00
Net Change in Cash2,613.00104.002,062.00
Free Cash Flow24,862.0020,705.0025,682.00
Preferred Dividends (Cash Flow)00.00
Price to Free Cash Flow28.0435.6826.10
values in Millions, USD

UnitedHealth Group Inc at a Glance

UnitedHealth Group Inc Financials at a glance including: EPS, Sales, Shares Outstanding, SPY Comparison, Short Interest, Short Interest History, EPS Performance and Forecast, GAAP EPS Performance and Forecast, Revenue Performance and Forecast, Price Reactions to Earnings Reports, Latest Revisions, Revenue by Products and Services, Revenue by Regions, Revenue by Segment, Dividends, and Dividend Payout History.
Please Note: Information edited and updated on 23/05/2025

Previous article
Next article
spot_img

Abbreviations

Index – Major index membership                          

Market Cap – Market capitalization

Income – Trailing 12 months income

Sales – Trailing 12 months revenue

Book/sh – Most recent quarter book value a share

Cash/sh – Most recent quarter cash per share Dividend Est. – Analysts’ dividend estimate (fiscal year) Dividend TTM – Trailing 12-month dividend Dividend Ex-Date – Ex-dividend date Employees – Number of full-time employees Option/Short – Stock has options on a market exchange/stock is available to sell short Sales Surprise – Last quarter revenue surprise SMA20 – Stock price distance from 20-day simple moving average P/E – Price-to-Earnings (trailing 12-months) Forward P/E – Forward Price-to-Earnings (next fiscal year) PEG – Price-to-Earnings-to-Growth P/S – Price-to-Book (most recent quarter) P/B – Price-to-Book (most recent quarter) P/C – Price to cash per share (most recent quarter) P/FCF – Price to Free Cash Flow (trailing 3-months) Quick Ratio – Quick Ratio (most recent quarter) Current Ratio – Current Ratio (most recent quarter) Debt/Eq – Total Debt to Equity (most recent quarter) LT Debt/Eq – Long Term Debt to Equity (most recent quarter) EPS Surprise – Last quarter Earnings-Per-Share surprise SMA50 – Stock price distance from 50-Day Simple Moving Average EPS (ttm) – Diluted Earnings-Per-Share (trailing 3-months) EPS next Y – Earnings-Per-Share estimate for next year EPS next Q – Earnings-Per-Share estimate next quarter EPS this Y - Earnings-Per-Share growth this year EPS next Y - Earnings-Per-Share estimate for next year EPS next 5Y – Long term annual growth estimate (5 years) EPS past 5Y – Annual Earnings-Per-Share growth past 5 years Sales past 5Y – Annual sales growth past 5 years EPS Y/Y TTM – Earnings-Per-Share growth (trailing 3 months) Sales Y/Y TTM – Sales growth (trailing 3 months) EPS Q/Q – Quarterly earnings growth (Year-on-Year) Sales Q/Q – Quarterly revenue growth (Year-on-Year) SMA200 – Stock price distance from 2-Day Simple Moving Average Insider Own – Percentage insider ownership of company shares Insider Trans – Insider transactions (6-month change in Insider Ownership) Inst Own – Institutional ownership Inst Trans - Institutional transactions (3-month change in Institutional Ownership) ROA – Return on Assets (trailing 3-months) ROE – Return on Equity (trailing 3-months) ROI – Return on Investment (trailing 3-months) Gross Margin – Gross Margin (trailing 3-months) Oper. Margin – Operating Margin (trailing 3-months) Profit Margin – Net Profit Margin (trailing 3-months) Payout – Dividend Payout Ratio (trailing 3-months) Earnings – BMO = Before Market Open / AMC = After Market Close Shs Outstand – Shares outstanding Shs Float – Shares float Short Float – Short interest share Short Ratio – Short interest ratio Short Interest – Short interest 52W Range – 52-Week trading range 52W High – Distance from 52-Week High 52W Low - Distance from 52-Week Low RSI (14) – Relative Strength Index Perf Week – Performance (Week) Perf Month – Performance (Month) Perf Quarter – Performance (Quarter) Perf Half Y - Performance (Half Year) Perf Year – (Year) Perf YTD - Performance (Year-To-Date) Beta - Beta ATR (14) – Average True Range Volatility – Volatility (Week, Month) Target Price – Analysts’ mean target price Price – Current stock price

explore more

This website uses cookies. By continuing to use this site, you accept our use of cookies.